Showing results (111-120 of 397) with videos related to

Sort By:
Pageof 40
Wiener Klinische Wochenschrift|November 24, 1999
Long-term improvement of hematopoiesis following cyclosporine treatment in a patient with myelodysplastic syndromeA Berer, L Ohler, I Simonitsch, et al.
Wiener Klinische Wochenschrift|March 31, 1978
[Splenectomy in idiopathic thrombocytopenic purpura: short- and long-term results (author's transl)]M Francesconi, E Domanig, K Lechner, et al.
Haemostasis|January 1, 1982
Plasmapheresis: its value in the management of patients with antibodies to factor VIIIM Francesconi, C Korninger, E Thaler, et al.
Cancer Genetics and Cytogenetics|December 7, 2000
Variant intra philadelphia translocation with rearrangement of BCR-ABL and ABL-BCR within the same chromosome in a patient with cALLM Edelhäuser, W Raber, G Mitterbauer, et al.
Blut|October 1, 1983
Primary Hodgkin's disease of the lung. Case report and review of the literatureR Homan, K Lechner, E Neumann, et al.
Anticancer Research|May 1, 1994
MDR1 gene expression in myelodysplastic syndrome and in acute myeloid leukemia evolving from myelodysplastic syndromeS Zöchbauer, A Gsur, M Götzl, et al.
Annals of Hematology|August 31, 1999
Massive disseminated intravascular coagulation and hyperfibrinolysis in alveolar rhabdomyosarcoma: case report and review of the literatureM Fiegl, A Weltermann, R Stindl, et al.
American Journal of Clinical Pathology|July 9, 1999
Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (Humara). Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosisG Mitterbauer, K Winkler, H Gisslinger, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1989
Interleukin 3 activates human blood basophils via high-affinity binding sitesP Valent, J Besemer, M Muhm, et al.
Wiener Klinische Wochenschrift|January 1, 1996
[Clinical use of polymerase chain reaction in diagnosis and monitoring of malignant diseases]U Jäger, K Laczika, C Scholten, et al.
Pageof 40